Vetsys Pharmaceutical
Vetsys Pharmaceutical
The United Kingdom stands as a global beacon for high-standard animal welfare and agricultural productivity. With a livestock population exceeding 9 million cattle and nearly 20 million sheep, the demand for efficient, reliable, and stress-free parasite management is paramount. Pour-on solutions have revolutionized the British agricultural sector, offering a transdermal alternative to traditional oral or injectable treatments. In the humid climates of the Scottish Highlands or the lush pastures of the English Midlands, external parasite control is not just a health necessity but an economic imperative.
Post-Brexit, the UK's veterinary pharmaceutical market has seen a shift toward more resilient supply chains and localized sourcing strategies. British farmers and veterinarians increasingly seek products that comply with both domestic and international GMP (Good Manufacturing Practice) standards. As a premier manufacturer and exporter, we understand that the UK market requires precision—specifically, solutions that can withstand the unpredictable British weather while ensuring zero-residue for meat and dairy production under the "Farm to Fork" strategy.
Furthermore, the urban landscape of the UK, from London to Manchester, has seen a boom in the "humanization of pets." British pet owners demand clinical-grade, easy-to-apply solutions for feline and canine parasite control. Our export portfolio is specifically tuned to meet these stringent consumer expectations, combining safety with high efficacy.
Sheep Protected
GMP Compliance
Years Experience
Annual Global Sales
Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys), established in 2005, has emerged as a cornerstone of the animal health industry. With a registered capital of 30 million RMB, we have spent nearly two decades perfecting the science of veterinary medicine. Our facility is a marvel of modern engineering, housing specialized workshops for powders, premixes, injections, and our signature Pour-on solutions.
Operating under strict GMP protocols, Vetsys ensures that every liter of solution exported to the United Kingdom meets the rigorous safety benchmarks required for international trade. By 2015, our commitment to excellence propelled us to become a top-tier producer in China, with domestic sales exceeding USD 20 million, providing us with the financial stability to invest heavily in global expansion and sustainable R&D.
Vetsys is not just a manufacturer; we are a research-driven powerhouse. Our independent research institute features five specialized laboratories staffed by world-class scientists. This intellectual capital allows us to pioneer transdermal delivery systems that are more efficient and less invasive for animals.
Our manufacturing processes integrate AI-driven precision and automated systems to ensure consistency in every batch.
In the UK, farmers are adopting "Smart Farming" tools. Our pour-on solutions are designed to be compatible with automated applicator guns that record dosage per animal, ensuring precision and reducing waste.
The British Department for Environment, Food & Rural Affairs (DEFRA) emphasizes sustainable land use. Vetsys invests in green technologies to ensure our topical solutions have minimal impact on soil biodiversity.
Animal welfare is a top priority for British consumers. Pour-on treatments reduce the stress of handling and restraint, aligning with the UK's reputation for ethical farming practices.
We aim to be more than a supplier; we seek to be a partner in the British animal health ecosystem. Our strategy includes potential research collaborations with UK-based veterinary universities and expanding our logistics network to provide faster delivery to agricultural hubs across the British Isles. We are committed to shaping the future of animal healthcare through innovation, quality, and sustainability.
